HCP, Inc. is a self-administered real estate investment trust. The Company invests in real estate serving the healthcare industry in the United States. The Company's segments include senior housing triple-net (SH NNN), senior housing operating portfolio (SHOP), life science and medical office. Its senior housing facilities include independent living facilities, assisted living facilities, memory care facilities, care homes, and continuing care retirement communities. Its Life science properties contain laboratory and office space for biotechnology, medical device and pharmaceutical companies, scientific research institutions, government agencies and other organizations. Its Medical office buildings contain physicians' offices and examination rooms, and may include pharmacies, hospital ancillary service space and outpatient services. As of December 31, 2016, it had interests in and managed 15 hospitals, 61 care homes in the United Kingdom and five post-acute/skilled nursing facilities.
Industry, Sector and Symbol:
- Sector: Finance
- Industry: Healthcare REITs
- Sub-Industry: Specialized REITs
- Symbol: NYSE:HCP
- CUSIP: 40414L10
- Web: www.hcpi.com
Capitalization:- Market Cap: $13.07 billion
- Outstanding Shares: 468,963,000
Average Prices:- 50 Day Moving Avg: $29.61
- 200 Day Moving Avg: $30.98
- 52 Week Range: $27.61 - $36.16
P/E:- Trailing P/E Ratio: 19.00
- Foreward P/E Ratio: 39.25
- P/E Growth: 8.46
Sales & Book Value:- Annual Revenue: $2.02 billion
- Price / Sales: 6.47
- Book Value: $12.16 per share
- Price / Book: 2.29
Dividend:- Annual Dividend: $1.48
- Dividend Yield: 5.2%
Profitability:- EBIDTA: $1.17 billion
- Net Margins: 32.16%
- Return on Equity: 9.96%
- Return on Assets: 4.19%
Debt:- Debt-to-Equity Ratio: 1.22%
- Current Ratio: 1.68%
- Quick Ratio: 1.68%
Misc:- Average Volume: 3.37 million shs.
- Beta: 0.38
- Short Ratio: 4.9
Frequently Asked Questions for HCP (NYSE:HCP)
What is HCP's stock symbol?
HCP trades on the New York Stock Exchange (NYSE) under the ticker symbol "HCP."
How often does HCP pay dividends? What is the dividend yield for HCP?
HCP announced a quarterly dividend on Thursday, July 27th. Investors of record on Monday, August 7th will be given a dividend of $0.37 per share on Tuesday, August 22nd. This represents a $1.48 dividend on an annualized basis and a yield of 5.31%. The ex-dividend date of this dividend is Thursday, August 3rd. View HCP's Dividend History.
How were HCP's earnings last quarter?
HCP, Inc. (NYSE:HCP) released its quarterly earnings results on Tuesday, August, 1st. The company reported $0.48 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.47 by $0.01. The business had revenue of $458.90 million for the quarter, compared to analyst estimates of $456.29 million. HCP had a net margin of 32.16% and a return on equity of 9.96%. The business's quarterly revenue was down 14.8% compared to the same quarter last year. During the same period in the prior year, the company posted $0.71 earnings per share. View HCP's Earnings History.
When will HCP make its next earnings announcement?
What guidance has HCP issued on next quarter's earnings?
HCP issued an update on its FY17 earnings guidance on Tuesday, August, 1st. The company provided earnings per share (EPS) guidance of $1.89-1.95 for the period, compared to the Thomson Reuters consensus estimate of $1.94.
Where is HCP's stock going? Where will HCP's stock price be in 2017?
15 brokers have issued 1-year target prices for HCP's shares. Their forecasts range from $30.00 to $35.00. On average, they expect HCP's share price to reach $32.00 in the next twelve months. View Analyst Ratings for HCP.
Who are some of HCP's key competitors?
Some companies that are related to HCP include Ventas (VTR), Omega Healthcare Investors (OHI), Healthcare Trust of America (HTA), Medical Properties Trust (MPW), Healthcare Realty Trust Incorporated (HR), National Health Investors (NHI), Physicians Realty Trust (DOC), LTC Properties (LTC), Assura PLC (AGR), Universal Health Realty Income Trust (UHT), Primary Health Properties PLC (PHP), MedEquities Realty Trust (MRT), Community Healthcare Trust Incorporated (CHCT), Aviv REIT (AVIV), Care Capital Properties (CCP), CareTrust REIT (CTRE), Global Medical REIT (GMRE) and Sabra Healthcare REIT (SBRA).
Who are HCP's key executives?
HCP's management team includes the folowing people:
- Michael Dale McKee, Executive Chairman of the Board
- Thomas M. Herzog, Chief Executive Officer, Director
- Peter A. Scott, Chief Financial Officer, Executive Vice President
- Thomas M. Klaritch CPA, Chief Operating Officer, Executive Vice President
- Troy E. McHenry, Executive Vice President, General Counsel, Corporate Secretary
- Kendall K. Young, Executive Vice President - Senior Housing Investments
- Shawn G. Johnston, Senior Vice President, Chief Accounting Officer
- Kai Hsiao, Senior Managing Director - Senior Housing Properties
- David B. Henry, Lead Independent Director
- Brian G. Cartwright, Independent Director
Who owns HCP stock?
HCP's stock is owned by a number of of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (14.33%), BlackRock Inc. (9.93%), State Street Corp (5.83%), JPMorgan Chase & Co. (5.00%), Bank of New York Mellon Corp (2.78%) and Daiwa Securities Group Inc. (2.26%). Company insiders that own HCP stock include Darren A Kowalske, James Justin Hutchens, James P Hoffmann, Jonathan M Bergschneider, Kai Hsiao, Kendall K Young, Lauralee Martin, Peter L Rhein, Scott A Anderson, Thomas D Kirby and Thomas Klaritch. View Institutional Ownership Trends for HCP.
Who sold HCP stock? Who is selling HCP stock?
HCP's stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Balyasny Asset Management LLC, Thrivent Financial For Lutherans, Janus Henderson Group PLC, Hexavest Inc., Vanguard Group Inc., Prudential Financial Inc. and Capital Fund Management S.A.. Company insiders that have sold HCP stock in the last year include Scott A Anderson and Thomas Klaritch. View Insider Buying and Selling for HCP.
Who bought HCP stock? Who is buying HCP stock?
HCP's stock was acquired by a variety of institutional investors in the last quarter, including Royal Bank of Canada, Cbre Clarion Securities LLC, APG Asset Management US Inc., Russell Investments Group Ltd., Daiwa Securities Group Inc., BlackRock Inc., Standard Life Investments LTD and JPMorgan Chase & Co.. Company insiders that have bought HCP stock in the last two years include Darren A Kowalske, James Justin Hutchens, James P Hoffmann, Kendall K Young, Lauralee Martin and Thomas D Kirby. View Insider Buying and Selling for HCP.
How do I buy HCP stock?
Shares of HCP can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is HCP's stock price today?
One share of HCP stock can currently be purchased for approximately $27.87.
MarketBeat Community Rating for HCP (NYSE HCP)MarketBeat's community ratings are surveys of what our community members think about HCP and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for HCP (NYSE:HCP) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 1 Sell Rating, 13 Hold Ratings, 1 Buy Rating |
| Consensus Rating: | Hold (Score: 2.00) |
| Consensus Price Target: | $32.00 (14.82% upside) |
Analysts' Ratings History for HCP (NYSE:HCP)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 9/22/2017 | Bank of America Corporation | Downgrade | Buy -> Neutral | $33.00 -> $31.00 | High |  |
| 9/17/2017 | KeyCorp | Reiterated Rating | Hold | | Low | |
| 9/6/2017 | BMO Capital Markets | Reiterated Rating | Hold | $32.00 | Low | |
| 8/22/2017 | Stifel Nicolaus | Reiterated Rating | Hold | $30.00 | Medium | |
| 7/25/2017 | Jefferies Group LLC | Reiterated Rating | Hold | $33.00 | Low | |
| 7/24/2017 | Goldman Sachs Group, Inc. (The) | Downgrade | Buy -> Neutral | $35.00 -> $32.00 | Medium | |
| 7/5/2017 | Royal Bank Of Canada | Reiterated Rating | Hold | $31.00 | High | |
| 6/28/2017 | Mizuho | Reiterated Rating | Neutral | | Low | |
| 6/14/2017 | Raymond James Financial, Inc. | Upgrade | Underperform -> Outperform | $35.00 | Low | |
| 4/24/2017 | Evercore ISI | Downgrade | In-Line -> Underperform | | Medium | |
| 4/21/2017 | Mitsubishi UFJ Financial Group | Initiated Coverage | Hold | $32.00 | Low | |
| 3/20/2017 | Morgan Stanley | Upgrade | Underweight -> Equal Weight | $31.00 | Low | |
| 3/10/2017 | Robert W. Baird | Initiated Coverage | Neutral -> Neutral | $32.00 | Low | |
| 2/14/2017 | Barclays PLC | Boost Price Target | Equal Weight | $32.00 -> $33.00 | N/A | |
| 11/1/2016 | BTIG Research | Reiterated Rating | Neutral | | N/A | |
| 9/18/2016 | Argus | Reiterated Rating | Hold | | N/A | |
| 9/4/2016 | Wells Fargo & Company | Reiterated Rating | Hold | | N/A | |
| 8/24/2016 | Citigroup Inc. | Boost Price Target | Neutral | $34.00 -> $38.00 | N/A | |
| 3/16/2016 | J P Morgan Chase & Co | Reiterated Rating | Hold | | N/A | |
| 2/10/2016 | Hilliard Lyons | Downgrade | Buy | | N/A | |
| 12/17/2015 | Cowen and Company | Lower Price Target | Market Perform | $40.00 -> $39.00 | N/A | |
(Data available from 9/24/2015 forward)
Earnings History for HCP (NYSE:HCP)Earnings History by Quarter for HCP (NYSE HCP)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 10/30/2017 | | $0.17 | | | | | N/A | |
| 8/1/2017 | Q2 2017 | $0.47 | $0.48 | $456.29 million | $458.90 million | View | Listen | |
| 5/2/2017 | Q1 2017 | $0.48 | $0.51 | $514.82 million | $492.16 million | View | Listen | |
| 2/13/2017 | Q416 | $0.57 | $0.59 | $527.10 million | $540.00 million | View | N/A | |
| 11/1/2016 | Q316 | $0.71 | $0.72 | $634.11 million | $654.30 million | View | N/A | |
| 8/9/2016 | Q216 | $0.70 | $0.74 | $631.25 million | $662.20 million | View | N/A | |
| 5/9/2016 | Q116 | $0.69 | $0.69 | $621.93 million | $640.80 million | View | N/A | |
| 2/9/2016 | Q415 | $0.78 | $0.80 | $658.05 million | $668.00 million | View | N/A | |
| 11/3/2015 | Q315 | $0.77 | $0.79 | $599.42 million | $657.95 million | View | N/A | |
| 8/4/2015 | Q215 | $0.76 | $0.79 | $582.84 million | $607.50 million | View | Listen | |
| 5/5/2015 | Q115 | $0.78 | $0.79 | $585.51 million | $610.80 million | View | Listen | |
| 2/10/2015 | Q414 | $0.77 | $0.79 | $584.82 million | $603.53 million | View | Listen | |
| 11/4/2014 | Q314 | $0.76 | $0.75 | $534.60 million | $596.60 million | View | Listen | |
| 8/5/2014 | Q214 | $0.75 | $0.75 | $523.50 million | $536.12 million | View | Listen | |
| 5/6/2014 | Q114 | $0.74 | $0.75 | $518.87 million | $530.00 million | View | Listen | |
| 2/11/2014 | Q413 | $0.74 | $0.76 | $510.39 million | $530.30 million | View | Listen | |
| 10/29/2013 | Q313 | $0.76 | $0.79 | $520.90 million | $543.96 million | View | Listen | |
| 7/30/2013 | Q213 | $0.74 | $0.72 | $518.53 million | $516.30 million | View | Listen | |
| 4/30/2013 | Q113 | $0.72 | $0.74 | | $516.30 million | View | Listen | |
| 2/12/2013 | Q412 | $0.71 | $0.71 | $482.51 million | $508.49 million | View | Listen | |
| 10/30/2012 | Q312 | $0.69 | $0.69 | $466.58 million | | View | N/A | |
| 7/31/2012 | | $0.68 | $0.69 | | | View | N/A | |
| 5/1/2012 | | $0.66 | $0.67 | | | View | N/A | |
| 2/14/2012 | | $0.66 | $0.67 | | | View | N/A | |
| 10/31/2011 | | $0.66 | $0.67 | | | View | N/A | |
| 8/2/2011 | | $0.76 | $0.77 | | | View | N/A | |
| 5/3/2011 | | $0.46 | $0.56 | | | View | N/A | |
| 2/15/2011 | | $0.59 | $0.64 | | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for HCP (NYSE:HCP)2017 EPS Consensus Estimate: $1.99
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 2 | $0.48 | $0.71 | $0.60 |
| Q2 2017 | 2 | $0.47 | $0.47 | $0.47 |
| Q3 2017 | 2 | $0.45 | $0.46 | $0.46 |
| Q4 2017 | 2 | $0.46 | $0.47 | $0.47 |
(Data provided by Zacks Investment Research)
Current Dividend Information for HCP (NYSE:HCP)| Most Recent Dividend: | 8/22/2017 |
| Annual Dividend: | $1.48 |
| Dividend Yield: | 5.31% |
| Dividend Growth: | -0.10% (3 Year Average) |
| Payout Ratio: | 102.07% (Trailing 12 Months of Earnings)
109.63% (Based on This Year's Estimates)
208.45% (Based on Next Year's Estimates)
|
Dividend History by Quarter for HCP (NYSE HCP)| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 7/27/2017 | quarterly | $0.37 | 4.65% | 8/3/2017 | 8/7/2017 | 8/22/2017 |
| 4/27/2017 | quarterly | $0.37 | 4.72% | 5/4/2017 | 5/8/2017 | 5/23/2017 |
| 2/2/2017 | quarterly | $0.37 | 4.81% | 2/13/2017 | 2/15/2017 | 3/2/2017 |
| 11/1/2016 | quarterly | $0.37 | | 11/8/2016 | 11/10/2016 | 11/25/2016 |
| 7/28/2016 | quarterly | $0.58 | 5.86% | 8/4/2016 | 8/8/2016 | 8/23/2016 |
| 4/27/2016 | quarterly | $0.58 | 6.78% | 5/5/2016 | 5/9/2016 | 5/24/2016 |
| 1/28/2016 | quarterly | $0.58 | 6.29% | 2/4/2016 | 2/8/2016 | 2/23/2016 |
| 10/29/2015 | quarterly | $0.57 | 6.08% | 11/5/2015 | 11/9/2015 | 11/24/2015 |
| 7/30/2015 | quarterly | $0.57 | 5.85% | 8/6/2015 | 8/10/2015 | 8/25/2015 |
| 4/30/2015 | quarterly | $0.57 | 5.55% | 5/7/2015 | 5/11/2015 | 5/26/2015 |
| 1/29/2015 | quarterly | $0.57 | 4.78% | 2/5/2015 | 2/9/2015 | 2/24/2015 |
| 10/30/2014 | quarterly | $0.55 | 4.96% | 11/6/2014 | 11/10/2014 | 11/25/2014 |
| 7/31/2014 | quarterly | $0.55 | 5.22% | 8/7/2014 | 8/11/2014 | 8/26/2014 |
| 5/6/2014 | quarterly | $0.55 | | | 5/27/2014 | 5/6/2014 |
| 5/1/2014 | quarterly | $0.55 | 5.18% | 5/8/2014 | 5/12/2014 | 5/27/2014 |
| 1/30/2014 | | $0.53 | | 2/6/2014 | 2/10/2014 | 2/25/2014 |
| 1/30/2014 | quarterly | $0.55 | 5.57% | 2/6/2014 | 2/10/2014 | 2/25/2014 |
| 10/24/2013 | quarterly | $0.53 | 4.88% | 10/31/2013 | 11/4/2013 | 11/19/2013 |
| 7/25/2013 | quarterly | $0.53 | 4.63% | 8/1/2013 | 8/5/2013 | 8/20/2013 |
| 4/25/2013 | quarterly | $0.53 | 3.98% | 5/2/2013 | 5/6/2013 | 5/21/2013 |
| 1/25/2013 | quarterly | $0.53 | 4.48% | 1/31/2013 | 2/4/2013 | 2/19/2013 |
(Data available from 1/1/2013 forward)
Insider Trading and Institutional Ownership History for HCP (NYSE:HCP)Insider Ownership Percentage: 0.22%
Institutional Ownership Percentage: 89.60%
Insider Trades by Quarter for HCP (NYSE:HCP)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 6/13/2017 | Thomas Klaritch | Insider | Sell | 2,651 | $31.53 | $83,586.03 | |
| 3/16/2017 | Scott A Anderson | CAO | Sell | 10,000 | $29.94 | $299,400.00 | |
| 9/7/2016 | Thomas D. Kirby | Insider | Sell | 3,000 | $40.24 | $120,720.00 | |
| 8/31/2016 | Darren A Kowalske | Insider | Sell | 2,250 | $39.20 | $88,200.00 | |
| 8/24/2016 | Kendall K Young | Insider | Sell | 9,000 | $39.46 | $355,140.00 | |
| 8/23/2016 | Jonathan M Bergschneider | EVP | Sell | 7,651 | $39.78 | $304,356.78 | |
| 5/9/2016 | Kai Hsiao | EVP | Sell | 266 | $36.04 | $9,586.64 | |
| 2/12/2016 | Thomas D Kirby | EVP | Buy | 500 | $26.10 | $13,050.00 | |
| 2/11/2016 | Darren A Kowalske | EVP | Buy | 3,822 | $26.12 | $99,830.64 | |
| 2/11/2016 | Lauralee Martin | CEO | Buy | 25,000 | $25.39 | $634,750.00 | |
| 2/10/2016 | James Justin Hutchens | EVP | Buy | 10,000 | $27.47 | $274,700.00 | |
| 12/8/2015 | Peter L Rhein | Director | Sell | 5,600 | $36.43 | $204,008.00 | |
| 11/11/2015 | James Justin Hutchens | EVP | Buy | 3,000 | $33.09 | $99,270.00 | |
| 11/11/2015 | James P Hoffmann | Director | Buy | 10,000 | $33.00 | $330,000.00 | |
| 11/6/2015 | Kendall K Young | EVP | Buy | 2,900 | $33.95 | $98,455.00 | |
| 6/12/2015 | Thomas Klaritch | EVP | Sell | 32,875 | $38.20 | $1,255,825.00 | |
| 8/29/2014 | Thomas D Kirby | EVP | Sell | 672 | $43.25 | $29,064.00 | |
| 8/27/2014 | Thomas Klaritch | EVP | Sell | 2,925 | $42.74 | $125,014.50 | |
| 6/16/2014 | Thomas Klaritch | EVP | Sell | 40,000 | $41.29 | $1,651,600.00 | |
| 6/2/2014 | Kendall K Young | EVP | Sell | 5,114 | $42.12 | $215,401.68 | |
| 6/2/2014 | Peter L Rhein | Director | Sell | 5,000 | $41.89 | $209,450.00 | |
| 5/14/2014 | Susan Tate | EVP | Sell | 23,311 | $42.25 | $984,889.75 | |
| 5/15/2013 | Scott A Anderson | CAO | Sell | 3,826 | $54.07 | $206,871.82 | |
| 11/26/2012 | Thomas D Kirby | EVP | Sell | 1,000 | $46.05 | $46,050.00 | |
(Data available from 1/1/2013 forward)
Headline Trends for HCP (NYSE:HCP)
Latest Headlines for HCP (NYSE:HCP)
| Source: |
|
| Date | Headline |
|---|
 | HCP Enters Oversold Territory
www.nasdaq.com - September 22 at 6:01 PM |
 | HCP, Inc. (HCP) Stock Rating Lowered by Bank of America Corporation
www.americanbankingnews.com - September 22 at 7:44 AM |
| HCP (HCP) and Its Peers Critical Contrast
www.americanbankingnews.com - September 18 at 12:28 AM |
| HCP, Inc. (HCP) Rating Reiterated by KeyCorp
www.americanbankingnews.com - September 17 at 9:36 AM |
 | HCP Provides Update on Impact of Hurricane Irma - PR Newswire (press release)
www.prnewswire.com - September 16 at 11:43 PM |
| HCP, Inc. (HCP) Expected to Announce Quarterly Sales of $452.10 Million
www.americanbankingnews.com - September 11 at 5:50 AM |
 | Top 5 Big-Dividend Healthcare REITs Worth Considering - Seeking Alpha
seekingalpha.com - September 10 at 11:32 PM |
| HCP: Turnaround Taking Shape, 5% Dividend Yield Pays Investors Well To Wait
seekingalpha.com - September 10 at 4:56 AM |
 | REIT Stock Performance Review -- Welltower, HCP Inc., Medical Properties Trust, and Omega Healthcare Investors
www.bizjournals.com - September 8 at 7:58 PM |
| HCP, Inc. (HCP) Receives Average Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - September 6 at 8:44 PM |
| HCP, Inc. (HCP) Stock Rating Reaffirmed by BMO Capital Markets
www.americanbankingnews.com - September 6 at 1:28 PM |
 | HCP, Inc. : HCP-US: Dividend Analysis : August 07th, 2017 (record date) : By the numbers : September 1, 2017
finance.yahoo.com - September 1 at 7:44 PM |
| HCP Provides Update on Impact of Hurricane Harvey - PR Newswire (press release)
www.prnewswire.com - September 1 at 12:20 AM |
 | You Wouldn't Believe the Size of HCP Inc.'s Market Opportunity - Motley Fool
www.fool.com - September 1 at 12:20 AM |
| You Wouldn't Believe the Size of HCP Inc.'s Market Opportunity
finance.yahoo.com - September 1 at 12:20 AM |
| HCP Provides Update on Impact of Hurricane Harvey
finance.yahoo.com - September 1 at 12:20 AM |
| You Wouldn't Believe the Size of HCP Inc.'s Market Opportunity
www.fool.com - August 31 at 9:19 PM |
| HCP Appoints Tom Klaritch As COO; Doug Pasquale To Serve As Senior Advisor
www.nasdaq.com - August 31 at 7:19 PM |
| HCP Announces Changes to Executive Leadership Team
finance.yahoo.com - August 31 at 7:19 PM |
 | HCP, Inc. (HCP) Names Tom Klaritch as COO - StreetInsider.com - StreetInsider.com
www.streetinsider.com - August 31 at 5:28 AM |
| Can Deleveraging Efforts Aid HCP Ride the Growth Curve? - Nasdaq
www.nasdaq.com - August 24 at 7:27 AM |
| $451.74 Million in Sales Expected for HCP, Inc. (HCP) This Quarter
www.americanbankingnews.com - August 23 at 8:36 AM |
| HCP, Inc. to Post Q3 2017 Earnings of $0.45 Per Share, Jefferies Group Forecasts (HCP)
www.americanbankingnews.com - August 23 at 8:22 AM |
| HCP, Inc. (HCP) Receives "Hold" Rating from Stifel Nicolaus
www.americanbankingnews.com - August 22 at 8:30 AM |
| Zacks: Analysts Expect HCP, Inc. (HCP) to Announce $0.47 EPS
www.americanbankingnews.com - August 22 at 12:18 AM |
| Medical Marijuana, Inc. Announces State of Mexico's Historic Purchase of Company's Cannabis Product for Its Citizens
www.prnewswire.com - August 21 at 6:41 PM |
| SPHD, IRM, KIM, HCP: Large Outflows Detected at ETF
www.nasdaq.com - August 18 at 7:13 PM |
| HCP, Inc. (HCP) Receives Consensus Rating of "Hold" from Analysts
www.americanbankingnews.com - August 12 at 8:34 PM |
| 3 Stocks Retirees Should Buy on a Market Pullback
www.fool.com - August 11 at 10:05 PM |
| Earnings Review and Free Research Report: Welltower Reported Better than Expected Revenue and FFO Results
finance.yahoo.com - August 11 at 7:54 PM |
| See what the IHS Markit Score report has to say about HCP Inc.
finance.yahoo.com - August 11 at 7:54 PM |
| Head-To-Head Review: HCP (NYSE:HCP) and National Health Investors (NHI)
www.americanbankingnews.com - August 10 at 10:24 PM |
| Good, Bad, And Ugly REITs
finance.yahoo.com - August 10 at 5:44 AM |
| HCP - A Stock For Investors Young And Old - Seeking Alpha
seekingalpha.com - August 8 at 4:57 AM |
| Spec office/medical project underway in Sugar Land
www.bizjournals.com - August 6 at 11:04 PM |
| HCP, Inc. (HCP) Expected to Announce Quarterly Sales of $462.02 Million
www.americanbankingnews.com - August 5 at 7:08 AM |
| HCP, Inc. (HCP) to Post FY2017 Earnings of $1.91 Per Share, KeyCorp Forecasts
www.americanbankingnews.com - August 4 at 11:08 AM |
| Back to life: Chinese research group revives Richmond manufacturing campus
www.bizjournals.com - August 4 at 5:28 AM |
| HCP Dividend Yield Pushes Past 5% - Nasdaq
www.nasdaq.com - August 4 at 12:27 AM |
| How HCP, Inc. Makes Most of Its Money - Motley Fool
www.fool.com - August 4 at 12:27 AM |
| How HCP, Inc. Makes Most of Its Money
www.fool.com - August 3 at 9:49 PM |
| Brokerages Anticipate HCP, Inc. (HCP) to Post $0.47 EPS
www.americanbankingnews.com - August 3 at 6:10 PM |
| HCP, Inc. Expected to Post Q3 2017 Earnings of $0.46 Per Share (NYSE:HCP)
www.americanbankingnews.com - August 3 at 8:28 AM |
| Edited Transcript of HCP earnings conference call or presentation 1-Aug-17 4:00pm GMT
finance.yahoo.com - August 3 at 5:54 AM |
| How Did Welltower Do in I2Q17 Results?
finance.yahoo.com - August 2 at 7:53 PM |
| What’s Ahead for Welltower in the Rest of the Year?
finance.yahoo.com - August 2 at 7:53 PM |
| Welltower’s Main Revenue Drivers in 2Q17
finance.yahoo.com - August 2 at 7:53 PM |
| Welltower’s Strategic Capital Deployment Maintained Profit in Q2
finance.yahoo.com - August 2 at 7:53 PM |
| How Welltower Fared in Terms of Cost Control in 2Q17
finance.yahoo.com - August 2 at 7:53 PM |
| How Welltower Rewarded Stockholders in 2Q17
finance.yahoo.com - August 2 at 7:53 PM |
HCP (HCP) Chart for Sunday, September, 24, 2017
